Mankind Pharma Ltd. (MANKIND)
NSE
Closed
Sep 9, 2026
Day's Range
2,252.0052 wk Range
1,909.70Overview - MANKIND - Mankind Pharma Ltd.
Key Statistics
Valuation
Enterprise Value
1.00T
P/E (Trailing)
‪46.77‬
P/E (Forward)
‪32.73‬
PEG Ratio
‪1.34‬
Price / Sales (TTM)
‪6.46‬
Price / Book
‪5.84‬
EV / EBITDA
‪25.83‬
Profitability
Gross Margin
‪72.75%‬
Profit Margin
‪13.85%‬
Operating Margin
‪20.60%‬
Return on Assets
‪6.81%‬
Return on Equity
‪11.55%‬
Ownership
Shares Outstanding
413.04M
Float
112.94M
Held by Insiders
‪75.39%‬
Held by Institutions
‪19.53%‬
Price stats
Beta
‪0.45‬
50-Day Avg
‪2,468.18‬
200-Day Avg
‪2,277.68‬
Dividends
Payout Ratio
‪2.02%‬
Analyst Consensus
19 analysts
Market Cap - MANKIND - Mankind Pharma Ltd.
Peers - MANKIND - Mankind Pharma Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NSE.
- MANKINDNSEMankind Pharma Ltd.953.72BMarket Cap-15.82%52-week change46.78P/E (Trailing)‪13.85%‬Profit Margin
- DIVISLABNSEDivi's Laboratories Ltd.2.45TMarket Cap+34.05%52-week change95.31P/E (Trailing)‪26.04%‬Profit Margin
- CIPLANSECipla Ltd.1.14TMarket Cap-11.50%52-week change34.09P/E (Trailing)‪12.00%‬Profit Margin
- LAURUSLABSNSELaurus Labs Ltd.1.04TMarket Cap+55.80%52-week change95.68P/E (Trailing)‪15.04%‬Profit Margin
- LUPINNSELupin Ltd.992.95BMarket Cap+12.96%52-week change18.10P/E (Trailing)‪18.45%‬Profit Margin
- DRREDDYNSEDr. Reddy's Laboratories Ltd.981.26BMarket Cap-8.65%52-week change29.70P/E (Trailing)‪9.99%‬Profit Margin
- AUROPHARMANSEAurobindo Pharma Ltd.951.15BMarket Cap+37.08%52-week change25.98P/E (Trailing)‪10.62%‬Profit Margin
Profile Summary - MANKIND - Mankind Pharma Ltd.
About
Mankind Pharma Ltd. is a prominent pharmaceutical company based in India, focusing on the development, manufacturing, and marketing of a diverse range of pharmaceutical products. The company is recognized for its extensive portfolio that includes prescription medications, over-the-counter products, and a variety of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
